UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study

British journal of surgery, 2021-07, Vol.108 (7), p.817-825

2021

Link zum Volltext

Verfügbarkeit prüfen

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

ESMO open, 2022-06, Vol.7 (3), p.100427-100427, Article 100427

2022

Link zum Volltext

Verfügbarkeit prüfen

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

The Lancet regional health. Europe, 2021-04, Vol.3, p.100049-100049, Article 100049

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

ESMO open, 2021-08, Vol.6 (4), p.100208-100208, Article 100208

2021

Link zum Volltext

Verfügbarkeit prüfen

20P Switching to S-1-based adjuvant treatment is feasible in colorectal cancer patients after cardiotoxicity on fluoropyrimidine-based treatment: A retrospective multicentre observational study

Annals of oncology, 2024-06, Vol.35, p.S10-S10

2024

Link zum Volltext

Verfügbarkeit prüfen

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer

British journal of cancer, 2011-07, Vol.105 (2), p.255-262

2011

Link zum Volltext

Verfügbarkeit prüfen

65P Costs and resource utilization in the curative and palliative treatment phases of metastatic colorectal cancer: Patient-level data analysis of the Finnish RAXO study

Annals of oncology, 2024-06, Vol.35, p.S31-S31

2024

Link zum Volltext

Verfügbarkeit prüfen

606P Regional lymph nodes (N+ vs N0) in metastatic colorectal cancer

Annals of oncology, 2023-10, Vol.34, p.S435-S436

2023

Link zum Volltext

Verfügbarkeit prüfen

607P Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy +/- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy)

Annals of oncology, 2023-10, Vol.34, p.S436-S437

2023

Link zum Volltext

Verfügbarkeit prüfen

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

Supportive care in cancer, 2017-09, Vol.25 (9), p.2771-2777

2017

Link zum Volltext

Verfügbarkeit prüfen

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

International journal of cancer, 2024-02, Vol.154 (3), p.488-503

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit

ESMO open, 2021-06, Vol.6 (3), p.100175-100175, Article 100175

2021

Link zum Volltext

Verfügbarkeit prüfen

E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer

Oncology reports, 2005-05, Vol.13 (5), p.831

2005

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer

Annals of oncology, 2002-12, Vol.13 (12), p.1868-1873

2002

Link zum Volltext

Verfügbarkeit prüfen

KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Frontiers in oncology, 2022-02, Vol.12, p.826073-826073

2022

Link zum Volltext

Verfügbarkeit prüfen

396P Resectability, resections, systemic treatment and outcomes in elderly metastatic colorectal cancer (mCRC) patients (the RAXO study)

Annals of oncology, 2021-09, Vol.32, p.S536-S536

2021

Link zum Volltext

Verfügbarkeit prüfen

Low Collagenase-1 (MMP-1) and MT1-MMP Expression Levels Are Favourable Survival Markers in Advanced Colorectal Carcinoma

Oncology, 2003-01, Vol.65 (4), p.337-346

2003

Link zum Volltext

Verfügbarkeit prüfen

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

British journal of surgery, 2023-07, Vol.110 (8), p.931-935

2023

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region

Cancer research (Chicago, Ill.), 2003-04, Vol.63 (8), p.1920-1926

2003

Link zum Volltext

Verfügbarkeit prüfen

CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer

Oncology reports, 2004-01, Vol.11 (1), p.41

2004

Link zum Volltext

Verfügbarkeit prüfen

Novel serum inflammatory markers in acute appendicitis

Scandinavian journal of clinical and laboratory investigation, 2002, Vol.62 (8), p.579-584

2002

Link zum Volltext

Verfügbarkeit prüfen

Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?

British journal of cancer, 2012-01, Vol.106 (2), p.428-428

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(71)
Finnisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(36)
Oncology
(34)
Female
(29)
Male
(29)
Aged
(26)
Middle Aged
(26)
Adult
(25)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Colorectal Cancer
(17)
Tumors
(17)
Medicin Och Hälsovetenskap
(15)
Colorectal Neoplasms - Pathology
(14)
Aged, 80 And Over
(13)
Prognosis
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Colorectal Neoplasms - Drug Therapy
(11)
Colorectal Carcinoma
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study

Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

20P Switching to S-1-based adjuvant treatment is feasible in colorectal cancer patients after cardiotoxicity on fluoropyrimidine-based treatment: A retrospective multicentre observational study

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer

65P Costs and resource utilization in the curative and palliative treatment phases of metastatic colorectal cancer: Patient-level data analysis of the Finnish RAXO study

606P Regional lymph nodes (N+ vs N0) in metastatic colorectal cancer

607P Impact of primary tumour sidedness (PTS) on demographics, resectability, and outcome after metastasectomy +/- local ablative therapy (LAT), or systemic therapy in metastatic colorectal cancer patients (a RAXO substudy)

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit

E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer

KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

396P Resectability, resections, systemic treatment and outcomes in elderly metastatic colorectal cancer (mCRC) patients (the RAXO study)

Low Collagenase-1 (MMP-1) and MT1-MMP Expression Levels Are Favourable Survival Markers in Advanced Colorectal Carcinoma

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region

CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer

Novel serum inflammatory markers in acute appendicitis

Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

Suchergebnisse filtern